CHARLES BARRIOS: Open Payments
NPI 1023232162 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 75 payments from 11 companies in 2025. Trend: 2023 $1,442 · 2024 $1,134 · 2025 $1,438
Food & beverage: $1,329Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 21 | $344 |
| E.R. Squibb & Sons, L.L.C. | 18 | $300 |
| Axsome Therapeutics, Inc. | 8 | $174 |
| Alkermes, Inc. | 8 | $171 |
| Vanda Pharmaceuticals Inc. | 6 | $124 |
| Neurocrine BioSciences, Inc. | 3 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Lundbeck LLC | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
Products named: COBENFY, AUSTEDO XR, Auvelity, ARISTADA, INGREZZA, HETLIOZ, REXULTI, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
